| Autor: |
De Mello RA; Post-graduation Program in Medicine, Precision Oncology & Health Economics Research Group (OncoPRECH), Faculty of Medicine, Nine of July University (UNINOVE), São Paulo, Brazil.; Division of Medical Oncology/Oncotorax Group, Escola Paulista de Medicina, Federal University of São Paulo (UNIFESP), São Paulo, Brazil.; Algarve Biomedical Centre, Department of Biomedical Sciences and Medicine, University of Algarve (UALG), Faro, Portugal., Zhu JH; Department of Surgery, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China., Iavelberg J; Post-graduation Program in Medicine, Precision Oncology & Health Economics Research Group (OncoPRECH), Faculty of Medicine, Nine of July University (UNINOVE), São Paulo, Brazil., Potim AH; Post-graduation Program in Medicine, Precision Oncology & Health Economics Research Group (OncoPRECH), Faculty of Medicine, Nine of July University (UNINOVE), São Paulo, Brazil., Simonetti D; Post-graduation Program in Medicine, Precision Oncology & Health Economics Research Group (OncoPRECH), Faculty of Medicine, Nine of July University (UNINOVE), São Paulo, Brazil., Silva JA Jr; Post-graduation Program in Medicine, Precision Oncology & Health Economics Research Group (OncoPRECH), Faculty of Medicine, Nine of July University (UNINOVE), São Paulo, Brazil., Castelo-Branco P; Algarve Biomedical Centre, Department of Biomedical Sciences and Medicine, University of Algarve (UALG), Faro, Portugal., Pozza DH; Department of Biomedicine & I3S, Faculty of Medicine, University of Porto (FMUP), Porto, Portugal., Tajima CC; Hospital São José & Hospital São Joaquim-Beneficência Portuguesa de São Paulo, São Paulo, Brazil., Tolia M; Department of Radiotherapy/Radiation Oncology, Faculty of Medicine, School of Health Sciences, University of Thessaly, University Hospital of Larisa, Biopolis, Greece., Antoniou G; Division of Thoracic Oncology, Mont Vernon Cancer Center, London, UK. |
| Abstrakt: |
Competing Interests: Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/tlcr-20-625). RADM serves as an unpaid editorial board member of Translational Lung Cancer Research from Jan 2020 to Dec 2021. RADM reports Consultant/advisory board for Pfizer, Zodiac, MSD, European School of Oncology (ESO); Speaker Honoraria from Astrazenenca, Novartis, Merck, Astellas, ESO; volunteer speaker role for ASCO 2016–2019; Faculty for the Educational Committee of the European Society for Medical Oncology (ESMO), 2018–2022; Faculty for the Cancer Educational Committee of the American Society of Clinical Oncology (ASCO), 2016–2019; Educational Grants: Merck-Group; Travel Grant: Astellas. Research Grant: Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPQ), Brazil, number 402621/2016-6. Expert honoraria from National Science Center, Poland, and National Medical Research Council, Singapore. Honorary Grant Reviewer for British Lung Foundation, United Kingdom. The other authors have no conflicts of interest to declare. |
